Inactive Instrument
IRLAB Therapeutics AB Stock Nasdaq Stockholm
Stocks
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 09-03 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| 09-03 | Irlab CEO Kristina Torfgaard wants to step down | FW |
| Market Cap | 274M 27.32M 24.11M 22.81M 20.69M 38.78M 2.62B 39.16M 105M 1.34B 103M 100M 4.31B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 274M 27.32M 24.11M 22.81M 20.69M 38.78M 2.62B 39.16M 105M 1.34B 103M 100M 4.31B | EV / Sales 2026 * |
2.7x | EV / Sales 2027 * | 1.91x |
| Free-Float |
83.4% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/08/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 01/01/2013 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 01/01/2016 |
| Chairman | 73 | 07/05/2020 | |
Veronica Wallin
BRD | Director/Board Member | 40 | 01/01/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | +1.24% | +63.06% | +120.55% | 1,056B | |
| -1.61% | -0.60% | +47.32% | +71.79% | 655B | |
| -1.12% | -0.72% | +17.98% | +76.63% | 471B | |
| -1.72% | -4.25% | +37.79% | +39.89% | 342B | |
| -0.40% | +4.12% | +22.89% | +29.04% | 277B | |
| -0.51% | -1.05% | +12.98% | +12.92% | 257B | |
| +1.32% | +3.27% | +54.63% | +57.63% | 226B | |
| -0.61% | -0.91% | +34.33% | +101.87% | 189B | |
| -0.24% | -3.21% | -27.79% | -61.37% | 170B | |
| Average | -0.55% | +0.97% | +29.24% | +49.88% | 404.77B | |
| Weighted average by Cap. | -0.59% | +1.04% | +39.20% | +70.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 101M 10.1M 8.92M 8.44M 7.65M 14.34M 969M 14.48M 39M 495M 37.94M 37.11M 1.59B | 143M 14.3M 12.62M 11.94M 10.83M 20.3M 1.37B 20.5M 55.19M 701M 53.68M 52.51M 2.25B |
| Net income | -36.1M -3.6M -3.18M -3.01M -2.73M -5.12M -346M -5.17M -13.91M -177M -13.53M -13.24M -568M | 34.6M 3.45M 3.05M 2.88M 2.62M 4.9M 331M 4.95M 13.34M 169M 12.97M 12.69M 545M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Calendar
Select your edition
All financial news and data tailored to specific country editions
